Sign up to save your podcasts
Or
Share Radionuclide Therapy May Enhance Cancer Cell Death Pathways
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Radionuclide Therapy May Enhance Cancer Cell Death Pathways
Radionuclide-stimulated dynamic therapy activates light-sensitive drugs with radiopharmaceuticals to produce cancer-killing reactive oxygen species, reprogram tumor immunity, and overcome resistance in aggressive cancers.
View all episodes
By TheBrief.HealthRadionuclide-stimulated dynamic therapy activates light-sensitive drugs with radiopharmaceuticals to produce cancer-killing reactive oxygen species, reprogram tumor immunity, and overcome resistance in aggressive cancers.